|
|||||
|
|
Triazolo and imidazo dihydropyrazolopyrimidine potassium channel antagonists |
|
| Authors: | Heather J Finlay Ji Jiang Yolanda Caringal Alexander Kover Mary Lee Conder Dezhi Xing Paul Levesque Timothy Harper Mei Mann Hsueh Karnail Atwal Michael Blanar Ruth Wexler John Lloyd |
| Institution: | 1. Department of Discovery Chemistry, Bristol-Myers Squibb, Research and Development, PO Box 5400, Princeton, NJ 08543-5400, United States;2. Department of Discovery Biology, Bristol-Myers Squibb, Research and Development, PO Box 5400, Princeton, NJ 08543-5400, United States;3. Department of Discovery Preclinical Candidate Optimization, Bristol-Myers Squibb, Research and Development, PO Box 5400, Princeton, NJ 08543-5400, United States |
| Abstract: | Previously disclosed C6 amido and benzimidazole dihydropyrazolopyrimidines were potent and selective blockers of IKur current. Syntheses and SAR for C6 triazolo and imidazo dihydropyrazolopyrimidines series are described. Trifluoromethylcyclohexyl N(1) triazole, compound 51, was identified as a potent and selective Kv1.5 inhibitor with an acceptable PK and liability profile. |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ | |